← Back to markets
Gilead Sciences
GILD · Health Care · Biotechnology
$149.92
RS +16.2
Returns
| 7D | +0.8% |
| 1M | +14.3% |
| 3M | +18.3% |
| 6M | +2.7% |
| YTD | +23.6% |
| 1Y | +36.2% |
About Gilead Sciences
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19. It also develops medicines in therapeutic areas such as oncology and inflammation and cell therapy.